This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-001546-ndz3oarf | What is the significance of accelerated IFN response in VLP mediated protection? |
| cord-274377-57zy6unz | The authors describe amiodarone, but there are many molecules that have been found as ebola replication or pseudoviral entry inhibitors, had they looked at more molecules to see if the pH mechanism was common across them? |
| cord-296517-414grqif | Have Super- Spreaders Played a Role in Other Outbreaks? |
| cord-000547-adfigzc1 | Why does Coomassie Brilliant Blue R interact differently with different proteins? |
| cord-004335-bw3tziup | The dendritic cell system and its role in immunogenicity Dendritic cells and the control of immunity Visualizing priming of virus- specific CD8+ T cells by infected dendritic cells in vivo Endogenous MHC class II processing of a viral nuclear antigen after autophagy Systemic activation of dendritic cells by Toll- like receptor ligands or malaria infection impairs cross- presentation and antiviral immunity Dendritic cells in viral pathogenesis: Protective or defective? |
| cord-279152-yh7x7w2q | What mechanism might account for this extraordinary effect of a single hydroxyl group on virus- receptor interaction? |
| cord-344316-mwnnmwnw | -what's the future? |
| cord-004126-u6ts87ur | molecular mechanism of host range variation of influenza viruses Characterization of an avian influenza A( H5N1) virus isolated from a child with a fatal respiratory illness Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus A pandemic warning? |
| cord-284845-on97zu6w | Distinct immune response in two MERS- CoV- infected patients: can we go from bench to bedside? |
| cord-284845-on97zu6w | the major drug targets of the twenty- first century? |
| cord-300133-yc2wxgid | , Guinea Does this patient have Ebola virus disease? |
| cord-300133-yc2wxgid | virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo Diagnosis of Ebola haemorrhagic fever by RT- PCR in an epidemic setting Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription- PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome Laboratory diagnosis of Ebola and Marburg hemorrhagic fever Guidance for collection, transport, and submission of specimens for Ebola virus testing in the United States Extreme PCR: a breakthrough innovation for outbreaks? |
| cord-303647-c4umbcvn | do subclinical filovirus infections occur worldwide? |
| cord-288734-xinkqs6u | Ebola hemorrhagic fever: why were children spared? |
| cord-002500-9p2n8tjx | : what can we learn from the race to develop novel vaccines? |
| cord-002500-9p2n8tjx | WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation- assay- based diagnostic kit Which antibody functions are important for an HIV vaccine? |
| cord-003917-bswndfvk | Neglected Tropical Diseases? |
| cord-002185-oz7hras7 | A Systematic Screen of FDA- Approved Drugs for Inhibitors of Biological Threat Agents Development, pharmacology and clinical experience with clomiphene citrate Clomiphene citrate for ovulation induction in women with oligo- amenorrhoea Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents Possible hypothalamic impotencemale counterpart to hypothalamic amenorrhea? |
| cord-002185-oz7hras7 | Report Molecular Evidence of Sexual Transmission of Ebola Virus Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp A Randomized Controlled Trial of ZMapp ™ in Acute Ebola Virus Infection Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease? |
| cord-330647-w1bpeqzg | Are health care workers protected? |
| cord-272576-ez731lif | If a common directional change is observed, what types of changes likely reoccur in future epidemics caused by invasions from natural reservoir hosts? |
| cord-002463-qhtj1pef | : what should be done to combat the epidemic in 2014? |
| cord-256187-ofp7tupv | What is known about the mechanism underlying IFITM dependent inhibition of host cell entry of EBOV and other viruses? |
| cord-001513-p7v5p036 | This statement is not clear, does it mean that the others have progressed beyond the mouse EBOV model? |
| cord-001513-p7v5p036 | Would it be possible to explore for surface patches with similar physico- chemical features? |
| cord-001513-p7v5p036 | for this case? |
| cord-355737-o0y4rn0z | Evolutionary relationships of the Old World fruit bats( Chiroptera, Pteropodidae): another star phylogeny? |
| cord-355737-o0y4rn0z | These observations therefore prompt a key question: what is the origin and nature of the selective pressure that has driven accelerated NPC1 evolution in bats? |
| cord-000804-0hlj6r10 | Is Marburg virus enzootic in Gabon? |
| cord-000804-0hlj6r10 | The morbid anatomy of Marburg virus disease Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ- specific macrophages? |
| cord-000804-0hlj6r10 | Viral hemorrhagic fever- a vascular disease? |
| cord-354068-4qlk6y7h | A hitherto unknown infectious disease contracted from monkeys Filoviridae: A taxonomic home for marburg and ebola viruses? |
| cord-354068-4qlk6y7h | Recombinant human activated protein c for the postexposure treatment of ebola hemorrhagic fever Marburg and ebola hemorrhagic fevers: Does the primary course of infection depend on the accessibility of organ- specific macrophages? |
| cord-305653-f9vqn96o | Is the tide turning around? |
| cord-352492-6ihyiwgb | : what is its contribution to blood safety? |
| cord-346267-l08ld2cy | And second, by using evolutionary models that account for selection, can we infer more realistic estimates of the ages of these viruses? |
| cord-346267-l08ld2cy | First, can purifying selection mask the ancient history of RNA viruses? |
| cord-346267-l08ld2cy | HIV-2 Relaxed selection and the evolution of RNA virus mucin- like pathogenicity factors Immune and artificial selection in the haemagglutinin( H) glycoprotein of measles virus Increased positive selection pressure in persistent( SSPE) versus acute measles virus infections Can deleterious mutations explain the time dependency of molecular rate estimates? |
| cord-294342-7ycgd0h7 | Does low pH directly cause conformational changes in EBOV GP to induce fusion, or does it work via increasing the activity of cathepsins, or both[ 7, 20]? |
| cord-294342-7ycgd0h7 | The question now becomes: how readily does a fusion pore enlarge when connecting an EBOV envelope with an endosomal membrane? |
| cord-002676-zwkl1ywk | How does GP antagonise tetherin? |
| cord-002676-zwkl1ywk | How does NP complete its function? |
| cord-002676-zwkl1ywk | How does VP24 contribute to assembly and budding? |
| cord-002676-zwkl1ywk | How does VP40 associate with the inner leaflet? |
| cord-002676-zwkl1ywk | How does myosin-10 influence the localisation of intrafilopodia motility release? |
| cord-002676-zwkl1ywk | What is the mechanism used to control VP40 oligomerization? |
| cord-001542-f089bs8r | -beta an alternative treatment for chronic hepatitis C? |
| cord-001542-f089bs8r | Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever? |
| cord-001542-f089bs8r | Early epidemic dynamics of the West African 2014 Ebola outbreak: estimates derived with a simple two- parameter model Filoviruses": a real pandemic threat? |
| cord-001542-f089bs8r | Is β- interferon a promising therapeutic option for the management of hepatitis C? |
| cord-001542-f089bs8r | VP40 be a drug target? |
| cord-342052-v4y1xc90 | : hospital dissemination and intrafamilial spread Marburg hemorrhagic fever associated with multiple genetic lineages of virus Ebola virus as a foodborne pathogen? |
| cord-342052-v4y1xc90 | Hospital outbreak of Middle East respiratory syndrome coronavirus Progress audit of Biosecurity Queensland response activities at Cawarral in Evidence for Camel- to- Human Transmission of MERS coronavirus Is that a rodent in your luggage? |
| cord-342052-v4y1xc90 | Hyspignathus monstrosus Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection Statistical inference in a stochastic epidemic SEIR model with control intervention: Ebola as a case study Fruit bats as reservoirs of Ebola virus Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo Dissemination of Cefotaxime- M- Producing Escherichia coli isolates in poultry farms, but not swine farms, in China Experimental inoculation study indicates swine as a potential host for Hendra virus Foodborne transmission of Nipah virus Proportion of deaths and clinical features in Bundibugyo Ebola virus infection Biosecurity Authority, Ministry of Agriculture and Forestry Is Marburg virus enzootic in Gabon? |
| cord-342052-v4y1xc90 | Interferon- beta therapy prolongs survival in Rhesus macaque models of Ebola and Marburg hemorrhagic Fever Qualitative release assessment to estimate the likelihood of Henipavirus entering the United Kingdom MERS in South Korea and China: a potential outbreak threat? |
| cord-350565-mejd7blb | 11,323 deaths later, how far have we come? |
| cord-350565-mejd7blb | 2017-what is making elimination so difficult? |
| cord-350565-mejd7blb | : External situation report 9 Use of serological surveys to generate key insights into the changing global landscape of infectious disease Mapping a filoviral serologic footprint in the Democratic Republic of the Congo: who goes there? |
| cord-350565-mejd7blb | A placebocontrolled trial of antimicrobial treatment for acute otitis media Access to new medications for the treatment of drug- resistant tuberculosis: patient, provider and community perspectives Tradeoffs in introduction policies for the anti- tuberculosis drug bedaquiline: a modelbased analysis Population implications of the use of bedaquiline in people with extensively drug- resistant tuberculosis: are fears of resistance justified? |
| cord-350565-mejd7blb | If syndromic surveillance is the answer, what is the question? |